Healthcare -
Biotechnology - NASDAQ - US
$ 10.27
-2.38 %
$ 433 M
Market Cap
-3.4
P/E
URGN - TOTAL CURRENT ASSETS
Total Current Assets URGN - UroGen Pharma Ltd.
169 M
LAST VALUE
21.62%
2 YEAR CAGR
10.60%
5 YEAR CAGR
48.95%
10 YEAR CAGR